Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin C  COVID-19 treatment studies for Vitamin C  C19 studies: Vitamin C  Vitamin C   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality 46% Improvement Relative Risk c19early.com/c Bhowmik et al. Vitamin C for COVID-19 META ANALYSIS Favors vitamin C Favors control
Bhowmik, vitamin C meta analysis: 46% lower mortality [p<0.0001] https://c19p.org/bhowmik
copied to clipboard
Impact of high-dose vitamin C on the mortality, severity, and duration of hospital stay in COVID-19 patients: A meta-analysis
Bhowmik et al., Health Science Reports, doi:10.1002/hsr2.762 (meta analysis)
8 Aug 2022    Source   PDF   Share   Tweet
Meta analysis of 15 studies with 2,125 COVID-19 patients showing significantly lower mortality with high-dose vitamin C.
Currently there are 53 vitamin C for COVID-19 studies, showing 26% [12‑38%] lower mortality, 19% [-8‑39%] lower ventilation, 15% [0‑28%] lower ICU admission, 18% [2‑31%] lower hospitalization, and 8% [-14‑35%] higher cases.
risk of death, 46.0% lower, OR 0.54, p < 0.001, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Bhowmik et al., 8 Aug 2022, peer-reviewed, 4 authors.
Contact: research_safiq@yahoo.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit